Clinical Trial Update: Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating bevacizumab with hormonal therapy and radiotherapy for high-risk prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Benaroya Research Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED